藥物成份

共有 21098 個藥物成份

Innovance D-Dimer supplement：liquid; buffered saline solution with proteins (Heterophilic Blocking Reagent; HBR)

• 關聯藥證數量: 1

Inositol, contains not less than 97.0% of C6H12O6

• 關聯藥證數量: 1

Insstruction Leaflet: giving full assay details.\nQC Certificate: indicating the expected performance of the batch\nβ2GP1 Coated Wells: 12breakpart 8 well strips coated with human β2GP1 antigen.\nType II Sample Diluent: 2 bottles containing 50 ml of buffer for sample dilution.\nWash Buffer (20x Concentrate): 1 bottle containing 50 ml of a 20-fold concentrated buffer for washing the wells.\nβ2GP1 IgM Calibrators: 5 bottles each containing 1.2 ml of diluted human serum, with the following concentrations of anti-β2GP1 autoantibody: 300, 100, 33.3, 11.1, 3.7 U/ml.\nβ2GP1 IgM Positive Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\nβ2GP1 Negative Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\nβ2GP1 IgM Conjugate: 1 bottle containing 12 ml of purified peroxidase labeled antibody.\nTMB Substrate: 1 bottle containing 14 ml TMB substrate.\nStop Solution: 1 bottle containing 14 ml of 3M phosp

• 關聯藥證數量: 1

Instruction Leaflet: Giving full assay details.\nQC Certificate: Indicating the expected performance of the batch.\nCardiolipin Coated Wells: 12 breakapart 8 well strips coated with bovine cardiolipin antigen.\nType II Sample Diluent: 2 bottles containing 50 ml of buffer for sample dilution.\nType II Wash Buffer (20x concentrate): 1 bottle containing 50 ml of a 20-fold concentrated buffer for washing the wells.\nCardiolipin IgG Calibrators: 5 bottles each containing 1.2 ml of diluted human serum, with the following concentrations of anticardiolipin autoantibody: 100, 50, 25, 12.5, 6.25 MPL U/ml.\nCardiolipin IgG Positive Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\nCardiolipin Negative Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\nCardiolipin IgG Conjugate: 1 bottle containing 12 ml of purified peroxidase labeled antibody.\nTMB Substrate: 1 bottle containing 14 ml TMB substrate.

• 關聯藥證數量: 1

Instruction Leaflet: Giving full assay details.\nQC Certificate: Indicating the expected performance of the batch.\nCardiolipin Coated Wells: 12 breakapart 8 well strips coated with bovine cardiolipin antigen.\nType II Sample Diluent: 2 bottles containing 50 ml of buffer for sample dilution.\nType II Wash Buffer (20x concentrate): 1 bottle containing 50 ml of a 20-fold concentrated buffer for washing the wells.\nCardiolipin IgM Calibrators: 5 bottles each containing 1.2 ml of diluted human serum, with the following concentrations of anticardiolipin autoantibody: 100, 50, 25, 12.5, 6.25 MPL U/ml.\nCardiolipin IgM Positive Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\nCardiolipin Negative Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\nCardiolipin IgM Conjugate: 1 bottle containing 12 ml of purified peroxidase labeled antibody.\nTMB Substrate: 1 bottle containing 14 ml TMB substrate.

• 關聯藥證數量: 1

Instruction Leaflet: Giving full assay details.\nQC Certificate: Indicating the expected performance of the batch.\ndsDNA Coated Wells: 12 breakapart 8 well strips coated with calf thymus dsDNA antigen. Each plate is packaged in a resealable foil bag containing two desiccant pouches.\nType III Sample Diluent: 2 bottles containing 50 ml of buffer for sample diluent.\nType III Wash Buffer (20x Concentrate): 1 bottle containing 50 ml of a 20-fold concentrated buffer for washing the wells.\ndsDNA Calibrators: 5 bottles each containing 1.2 ml of diluted human serum, with the following concentrations of anti-dsDNA autoantibody: 1000, 333, 111, 37, 12.3 IU/ml.\ndsDNA Positive Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\ndsDNA Negative Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\ndsDNA Single Strandard Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is gi

• 關聯藥證數量: 1

Instruction Leaflet: giving full assay details.\nQC Certificate: indicating the expected performance of the batch.\nCardiolipin Coated Wells: 12 breakapart 8 well strips coated with bovine cardiolipin antigen. \nType II Sample Diluent: 2 bottles containing 50 ml of buffer for sample dilution.\nType II Wash Buffer (20x Concentrate): 1 bottle containing 50 ml of a 20-fold concentrated buffer for washing the wells.\nCardiolipin IgA Calibrators: 5 bottles each containing 1.2 ml of diluted human serum, with the following concentrations of anticardiolipin autoantibody: 100, 50, 25, 12.5, 6.25 MPL U/ml.\nCardiolipin IgA Positive Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\nCardiolipin IgA Negative Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\nCardiolipin IgA Conjugate: 1 bottle containing 12 ml of purified peroxidase labeled antibody.\nTMB Substrate: 1 bottle containing 14 ml TMB subst

• 關聯藥證數量: 1

Instruction Leaflet: giving full assay details.\nQC Certificate: indicating the expected performance of the batch.\nENA Coated Wells: 12 x 8 well strips coated with a mixture of purified antigens (SSA/Ro (60 and 52 kD), SSB/La, Sm, Sm/RNP, Scl-70 and Jo-1).\nType III Wash Buffer 20x concentrate: 1 bottle containing 50 ml of a 20x concentrated buffer for washing the wells.\nType III Sample Diluent: 2 bottles containing 50 ml of buffer for diluting the samples.\nENA Screen Cut-off Control: 1 bottle containing 1.9 ml of diluted stabilized human serum. The expected ENA result is given on the QC certificate.\nENA Screen Positive Control: 1 bottle containing 1.9 ml of diluted stabilized human serum. The expected ENA result is given on the QC certificate.\nENA Negative Control: 1 bottle containing 1.9 ml of diluted stabilized human serum. The expected ENA result is given on the QC certificate.\nENA Screen Conjugate: 1 bottle containing 12 ml of peroxidase labeled antibody to human IgG.\nTMB Substrate: 1 bottle conta

• 關聯藥證數量: 1

Instrument, equipment and supplies: BDProbeTec ET Instrument and Instrument Plates, BDProbeTec ET Lysing Heater, Lysing Rack and base, BDProbeTec ET Priming and Warming Heater, BDProbeTec ET Pipettor and Power Supply, BDProbeTec ET Urine Processing Kit (containing Urine Processing Pouches/UPPs), BDProbeTec ET Sample Tubes, Caps, and Pipette Tips, BDProbeTec ET Chlamydia trachomatis/Neisseria gonorrhoeae (CT/GC) Amplified DNA Assay Endocervical Specimen Collection and DRY TRANSPORT Kit or BDProbeTec ET Chlamydia trachomatis/Nesseria gonorrhoeae (CT/GC) Amplified DNA Assay Collection Kit for Endocervical Specimens, BDProbeTec ET Chlamydia trachomatis/Neisseria gonorrhoeae (CT/GC) Amplified DNA Assay Male Urethral Specimen Collection and DRY TRANSPORT Kit or BDProbeTec ET Chlamydia trachomatis/Neisseria gonorrhoeae (CT/GC) Amplified DNA Assay Collection Kit for Male urethral Specimens.

• 關聯藥證數量: 1

Instrument: 2.5 x 4.5 x 9.0 inches\nCuvette: pre-loaded with dried thromboplastin with added stabilizers and buffers.

• 關聯藥證數量: 1

Insulin Bead Pack (L2IN12) : beads, coated with monoclonal murine anti-insulin antibody. \nInsulin Reagent Wedge (L2INA2) : alkaline phosphatase (bovine calf intestine) conjugated to polyclonal sheep anti-insulin antibody and alkaline phosphatase (bovine calf intestine) conjugated to monoclonal murine anti-insulin antibody in buffer.\nInsulin Adjustors (LINL, LINH) : Low and High Iyophilized insulin in a nonhuman serum matrix \nInsulin Controls (LINC1, LINC2) : lyophilized insulin in a nonhuman serum matrix

• 關聯藥證數量: 1

Insulin Test Units:\ncoated with monoclonal murine anti-insulin. \nInsulin Reagent Wedge:\nalkaline phosphatase (bovine calf intestine)conjugated to polyclonal sheep anti-insulin antibody and alkaline phosphatase (bovine calf intestine) conjugated to monoclonal murine anti-insulin antibody in buffer. \nInsulin Adjustors:\nTwo vials (Low and High) of lyophilized insulin in a nonhuman serum matrix. \nInsulin Controls:\nTwo vials of lyophilized insulin in a nonhuman serum matrix. \nInsulin Sample Diluent:\ninsulin-free nonhuman serum matrix.

• 關聯藥證數量: 1

Intact PHT Reagent: 200 beads, coated with affinity-purified murine monoclonal anti-PTH (44-84) antibody. 11.5 mL alkaline phosphatase (bovine calf intestine) conjugated to affinity-purified goat polyclonal anti-PTH (1-34) in buffer. Two vials (Low and High) of lyophilized, synthetic human intact PTH in a buffered matrix.\nIntact PTH Sample Diluent: 25 mL of concentrated PTH-free buffer matrix.

• 關聯藥證數量: 1

Intact PTH Adjustors : Two vials (Low and High) of lyophilized synthetic human intact PTH in a buffered matrix.

• 關聯藥證數量: 1

Intact PTH Test Units: one bead coated with affinity-purified murine monoclonal anti-PTH (44-84) antibody. Intact PTH Reagent Wedge: alkaline phosphatase (bovine calf intestine); conjugated to affinity-purified goat polyclonal anti-PTH (1-34) antibody in buffer, with preservative. Intact PTH Adjustors: synthetic human intact PTH in a buffered matrix.Sample Diluent: PTH-free buffer matrix, with preservative.

• 關聯藥證數量: 1

Ion Correct S is a liquid serum prepared from strictly selected normal human sera.

• 關聯藥證數量: 1

Ipecac Fluidextract

• 關聯藥證數量: 1

Ipratropium Bromide contains not less than 99.0% and not more than 100.5% of C20H30BrNO3‧H2O, calculated on the anhydrous substances.

• 關聯藥證數量: 1

Ipratropium Bromide contains not less than 99.0% and not more than 100.5% of C20H30BrNO3‧H2O, calculated on the dried basis.

• 關聯藥證數量: 1

Ipratropoium Bromide contains not less than 99.0% and not more than 100.5% of Ipratropoium bromide (C20H30BrNO3‧H2O), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Irbesartan contains not less than 98.0 percent and not more than 102.0 percent of C25H28N6O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Irbesartan contains not less than 98.0% and not more than 102.0% of C25H28N6O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Irbesartan contains not less than 98.0% and not more than 102.0% of C25H28N6O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Irbesartan contains not less than 98.0% and not more than 102.0% of C25H28N6O, calculated on the dried basis.

• 關聯藥證數量: 1

Irinotecan Hydrochloride Trihydrate contains not less than 98.0% and not more than 102.0% of C33H38N4O6‧HCl, calculated on anhydrous substance.

• 關聯藥證數量: 1

Irinotecan Hydrochloride contains not less than 98.0% and not more 102.0% of Irinotecan Hydrochloride (C33H38N4O6˙HCl), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Irinotecan Hydrochloride contains not less than 98.0% and not more than 102.0% of C33H38N4O6‧HCl, calculated on anhydrous substance.

• 關聯藥證數量: 1

Irinotecan Hydrochloride contains not less than 98.0% and not more than 102.0% of C33H38N4O6。HCl, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Iron (III) Hydroxide Polymaltose Complex [(Fe(OH)3(H2O)15)]n．[(C6H10O5)m]x Assay Polymaltose content (on Anhydrous basis): between 25.0 and 50.0%. ww Iron content (on as basis): between 25.0 and 40.0% ww

• 關聯藥證數量: 1

Iron (as Ferrous Fumarate)

• 關聯藥證數量: 1

Iron Color Reagent:\nFerrozine 7.8 mmol/L\nNeocuproine 14.4 mmol/L\nHydroxylamine Hydochloride 220 mmol/L\nIron HA Buffer:\nHydroxylamine Hydochloride 220 mmol/L、Surfactants\nIron TRIS Buffer:\nTRIS 500 mmol/L、Surfactants\n\n

• 關聯藥證數量: 1

Iron Solution 1 x 100 mL\nBasic Magnesium Carbonate 2 x 10 g

• 關聯藥證數量: 1

Iron Standard 500 μg/dl.\nReactive Ingredient: 0.09 mmol/l Ferrous ammonium sulfate. \nNonreactive Ingredient: Dilute Sulfuric acid.

• 關聯藥證數量: 1

Iron Sucrose Complex Solution ([Na2Fe5O8(oH)3H2O]n‧m(C12H22O11)]) Assay for Iron (by UV) Not less than 3.4% w/w. Assay for sucrose by HPLC (2.0% W/V of Iron solution) Not less than 260 mg and not more than 340 mg of sucrose per ml.

• 關聯藥證數量: 1

Iron Sucrose contains not less than 50.00 percent and not more than 65.00 percent of Sucrose and not less than 3.50 percent and not more than 4.00 percent of Iron on dried basis.

• 關聯藥證數量: 1

Isoleucine (L-Isoleucine), when dried, contains not less than 98.5% and not more than 101.0% of L-Isoleucine (C6H13NO2).

• 關聯藥證數量: 1

Isoleucine contains not less than 98.5% and not more than 101.5% of C6H13NO2, as L-Isoleucine, calculated on the dried basis.

• 關聯藥證數量: 1

Isoniazid contains not less than 98.0% and not more than 102.0% of C6H7N3O, calculated on the dried substance.

• 關聯藥證數量: 1

Isoniazid contains not less than 99.0% and not more than the equivalent of 101.0% of C6H7N3O calculated with reference to the dried substance.

• 關聯藥證數量: 1

Isoniazid contains not less than 99.0% and not more than the equivalent of 101.0% of C6H7N3O, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Isoniazid contains not less than 99.0% and not more than the equivalent of 101.0% of pyridine-4-carbohydrazide, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Isopropyl Alchol

• 關聯藥證數量: 1

Isopropyl Alcohol

• 關聯藥證數量: 1

Isoproyl alcohol, Polyethylene glycol, Purified water (Colourless liquid with almost no smell).

• 關聯藥證數量: 1

Isosorbide Mononitrate contains not less than 95.0% and not more than 105.0% of the labeled amount of isosorbide mononitrate (C6H9NO6)

• 關聯藥證數量: 1

Isoxsuprine HCl contains not less than 97.0% and not more than 103.0% of C18H23NO3‧HCl calculated on dried basis.

• 關聯藥證數量: 1

It contain buffer salts, <0.15% sodium azide and the following substances. \nSubstance Low High \nBovine Serum Albumin 0.45 g 0.3 g\nDigoxin * 0.02 μg\nN-acetylprocainamide ─ 0.15 mg\nProcainamide ─ 0.10 mg

• 關聯藥證數量: 1

It contains 97.0%~102.0% of Sacubitril and Valsartan (C48H55N6O8), calculated on anhydrous, solvent-free and free acid basis.

• 關聯藥證數量: 1

It contains of lyophilized serum and a package insert describing a table of analyte values.

• 關聯藥證數量: 1

It contains the equivalent of not less than 76.5 percent of Al(OH)3.

• 關聯藥證數量: 1

It has a potency equivalent to not less than 800 ug/mg of Clindamycin (C18H33ClN2O5S).

• 關聯藥證數量: 1

Itraconazole contains not less than 99% and not more than the equivalent of 101% of 4-[4-[4-[4-[[cis-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(1RS)-1-methylpropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one, calculated with the reference to the dried substance.

• 關聯藥證數量: 1

Itraconazole contains not less than 99.0% and not more than 101.0%.

• 關聯藥證數量: 1

Ivabradine Hydrochloride contains not less than 98.0 % and not more than 102.0 % of C27H37N2O5Cl, calculated on the dried basis.

• 關聯藥證數量: 1

Ivermectin contains: - not less than 95.0% and not more than 100.5% of H2B1a (C48H74O14) + H2B1b (C47H72O14) (anhydrous and solvent-free substance), - not less than 90.0% of H2B1a (C48H74O14) (as-is substance), - not more than 5.0% of H2B1b (C47H72O14) (as-is substance).

• 關聯藥證數量: 1

Ixekizumab

• 關聯藥證數量: 1

J: J-15R-J -20R/J-15S-J-19S; JE1: JE-21S

• 關聯藥證數量: 1

JAPANESE ANGELICA ROOT

• 關聯藥證數量: 1

JAPANESE ENCEPHALITIS INACTIVE VIRUS PROTEIN (NAKAYAMA STRAIN)

• 關聯藥證數量: 1

JAPANESE ENCEPHALITIS VACCINE

• 關聯藥證數量: 1

JAPANESE VALERIAN

• 關聯藥證數量: 1

JASMINE OIL

• 關聯藥證數量: 1

JIASMEN

• 關聯藥證數量: 1

JIFURAN (BIS-(5-NITRO-2-FURFURYLIDENE)-ACETONEGUA

• 關聯藥證數量: 1

JODI TINCTURE

• 關聯藥證數量: 1

JOSAMYCIN (PROPIONATE)

• 關聯藥證數量: 1

JOSAMYCIN PROPIONATE

• 關聯藥證數量: 1

JP Powdered Gambir

• 關聯藥證數量: 1

JP Powdered Geranium Herb

• 關聯藥證數量: 1

JP Powdered Glycyrrhiza

• 關聯藥證數量: 1

JP Powdered Phellodendron Bark

• 關聯藥證數量: 1

JUJUBE

• 關聯藥證數量: 1

Jack Bean Urease: 120 U/mL

• 關聯藥證數量: 1

Jo-1 ELISA High Positive

• 關聯藥證數量: 1

Jo-1 ELISA Low Positive

• 關聯藥證數量: 1

KAMALA

• 關聯藥證數量: 1

KANAMYCIN ACID SULFATE

• 關聯藥證數量: 1

KANAMYCIN B SULFATE (BEKANAMYCIN SULFATE)

• 關聯藥證數量: 1

KANZOFULAKUSU

• 關聯藥證數量: 1

KAOCHOL

• 關聯藥證數量: 1

KAOLIN

• 關聯藥證數量: 1

KAP 抗體卡 1 KAP 抗體(處理過的羊血清) 5.0ml 疊氮鈉(用作防腐劑) <0.1% (w/w)

• 關聯藥證數量: 1

KAWARATAKE(PROTEIN BINDING POLYSACCHARIDE EXTR. FR

• 關聯藥證數量: 1

KCI, 7.5 g/ CaCI2, 0.5 g/ Tricine N-[2-Hydroxy-1, 1-bis (hydroxymethyl) methyl] glycine / Tricine N-[2-hydroxy-1, 1-bis (hydroxymethyle) methyle] glycine / Trizin N-[2-Hydroxy-1, 1-bis (Hydroxymethyl) methyl] Glycin / Tricina N-[2-idrossi-1, 1-bis (idrossimetile) metile] glicina / Tricina N-[2-hidroxi-1, 1-bis (hidroximetil) metil] glicina, 0.895 g

• 關聯藥證數量: 1

KELCOLOID LVF

• 關聯藥證數量: 1

KERATIN

• 關聯藥證數量: 1

KETOCONAZOLE MICROFINE

• 關聯藥證數量: 1

KETOPROFEN SODIUM

• 關聯藥證數量: 1

KETOROLAC TROMETHAMINE, contains not less than 98.5% and not more than 101.5% of Ketorolac tromethamine calculated on the dried basis.

• 關聯藥證數量: 1

KETOTIFEN FUMARATE contains not less than 98.5% and not more than 101.0% of C19H19NOS, C4H4O4 calculated on the dried substance.

• 關聯藥證數量: 1

KET試紙: Goat anti-mouse antibody, KET/BSA Conjugate, Mouse anti-KET monoAb-colloidal gold conjugate.

• 關聯藥證數量: 1

KINASIN

• 關聯藥證數量: 1

KIT COMPONENTS(1) Substrate Reagent (R1)0.32 mg/mL of β-nicotinamide adenine dinucleotide phosphate reduction type.1.95 mg/mL of α-ketoglutaric acid(2) Enzyme Reagent (R2) 45 U/ml of urease, 60 U/mL of glutamate dehydrogenase

• 關聯藥證數量: 1

KIT COMPNENTS(1) Separation Reagent (R1)3.3 mg/mL of β-Nicotinamide adenine dinucleotide, oxidized form, anhydrous (β-NAD)(2) Enzyme Reagent (R2)20 U/mL of cholesterol dehydrogenase

• 關聯藥證數量: 1

KIT COMPONENTS QUANTITYAAT Cartridge 1Antibody Evaporation Caps2 AAT Reagent Bar Code Card 1 REAGENT CARTRIDGE CONSTITUENTS VOLUMEAAT Antibody (polyclonal anti-Alpha1-Antitrypsin 3.9 mLantibody; goat)Sodium Azide (used as a preservative) <0.1%(w/w)

• 關聯藥證數量: 1

KIT COMPONENTS QUANTITYIGM Cartridge 1 Antibody Antigen Excess Solution (AGXS)Evaporation Caps 2IGM Reagent Bar Code Card 1REAGENT CARTRIDGE CONSTITUENTS VOLUMEIGM Antibody (processed goat sera) 7.5 mLREAGENT CARTRIDGE CONSTITUENTS VOLUMEIGM Antigen Excess Solution (processed diluted human serum) 7.5 mLSodium Azide (used as a preservative) <0.1%(w/w)

• 關聯藥證數量: 1

KIT COMPONENTS QUANTITYTRF Cartridge 1AntibodyEvaporation Caps 2TRF Reagent Bar Code Card 1REAGENT CARTRIDGE CONSTITUENTS VOLUMETRF Antibody(processed goat sera) 3.9mL

• 關聯藥證數量: 1

KIT COMPONENTS 1)BUFFER2)ANTISERUM REAGENT TITER 1.6 MG/ML OF ANTI-HUMAN ALBUMIN ANTIBODY (RABBIT)

• 關聯藥證數量: 1

KIT COMPONENTS QUANTITYCRPH Cartridge 2Evaporation Caps 4CRPH Reagent Bar Code Card 1REAGENT CARTRIDGE CONSTITUENTS VOLUMECRP Antibody(particle bound goat and mouse anti- 7.8mLCRP antibody) 7.8mLDiluentSodium Azide (used as a preservative) <0.1%(w/w)Bovine Serum Albumin 0.1%(w/v)

• 關聯藥證數量: 1

KIT COMPONENTS(1) Buffer (R1)(2) Color Reagent (R2)2.47mg/mL of 3-(2-pyridyl)-5,6-bis(2-(5-furil sulfonate)) 1,2,4-triazine, disodium salt

• 關聯藥證數量: 1